CVS vs WAT
CVS Health vs Waters Corporation — AI-powered side-by-side comparison
VS
WAT
Waters Corporation
52
Watch
| Metric | CVS | WAT |
| AI Score |
53
|
52
|
| Price |
$93.07
|
$408.10
|
| P/E Ratio |
24.29×
|
102.16×
|
| ROE |
2.4%
|
25.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.2%
|
50.8%
|
| Debt / Equity |
0.96×
|
0.35×
|
| Dividend Yield |
2.9%
|
0.0%
|
| RSI (14) |
30.0
|
57.5
|
| Beta |
0.596
|
1.184
|
| Expected Upside |
+3.8%
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for CVS versus WAT.
CVS leads by 1 points.
CVS scores 53/100 (Watch) versus WAT at 52/100 (Watch).
CVS Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.84 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price-to-book of 1.3x is a discount to asset value — Value
- Dividend yield of 3.5% pays you to wait — Value
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- P/E of 25.0 is moderate-to-rich — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
WAT Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Value Analyst remains cautious — p/e of 245.9 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 52.5% YoY -- genuine top-line momentum — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 245.9 is expensive by classic value standards — Value
- Price-to-book of 8.8x prices in significant intangible value — Value
- ROE of only 1.9% -- cheap may mean cheap for a reason — Value